Company intelligence / Profile preview

BioDatomics

Bethesda, Maryland, United States

Ownership: Private
Employees: ~2
Development stage: Other

Overview

BioDatomics is a bioinformatics software company that develops BioDT, an open-source next-generation sequencing (NGS) data analysis platform. BioDT processes data up to 100 times faster than comparable systems, reducing analysis turnaround times from days or weeks to hours. It features an intuitive drag-and-drop interface, supports real-time collaboration, and integrates with over 400 analysis tools including the Galaxy library.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Digicon - BioDT selected for BioGenLink services

Beyond the preview

Go deeper on BioDatomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioDatomics.

Explore the full profile